Use of stearic acid for prevention or treatment of lung fibrosis

Item Number: 623
Industry: Therapeutic
Category: Fibrosis
Development Stage: Early Stage
Organisation Type: Private Corporation
Country: South Korea
Patent: Korea
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The present invention relates to a pharmaceutical composition for the prevention or treatment of lung fibrosis, comprising stearic acid or its pharmaceutically acceptable salts and antifibrotic agents thereof as an active ingredient.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it